APPLICATION INSTRUCTION
VALOSED
Paramedical mean

DRUG FORM: Tablets.
COMPOSITION: Active substance: Dry extract of Valosed – 0,05 g (Valerian rhizome and roots – 3 part; Motherwort grass – 3 part; Mint leaves – 2 part; Melissa grass – 2 part; Hop cones – 1 part; Hawthorn flowers -1 part);
Aiding substances: Magnesium subcarbonate, talc, starch, calcium or magnesium stearate,povidone, magnesium carbonate, sucrose, aerosol, titanium dioxide, blue colour.
Valosed consists of complex of biologically active substances: essential oils (borneolizovalerianate, borneol, izovalerian acid, menthol), valepotriats, phlavonoids (quercetin, rutin, quinqvelozid), triterpenic saponins, vitamins, tanines, spicy glycosides, lupuline, humulone, lupulone, ursule and olaine acids.
PHARMACOLOGICAL ACTION: Preparation has sedative spasmolitic, hypotensive, cardiotonic, anticonvulsant, analgesic, saluretic effect, it increases delaying processes in neurons of cerebral subcortical and cortical structures, reduces reflective irritation in the central parts of nervous system, prolongs the action of sedatives, reduces spontan action activity, relieves the neurogenic arrhythmias, dilates the brain vessels by reflex, reduces spasms of smooth muscles of the internal organs, increases the bile secretion, digestive glands secretion, peristaltic, regulates the fat and water-salt metabolism.
INDICATION: IT IS USED IN COMPLEX THERAPY, AS AN AID MEAN:
· Different types of neurosis, among them climacteric neurosis;
· Excitation, fear, tenseness;
· Migraines;
· Neurogenic arrhythmias;
· Hypertensive Disease (I,II stage);
· Hepato-biliary tract disease (cholecystitis, cholangitis);
· Secretion function disorder of gastro intestinal tract;
· Meteorism, nausea.
SIDE EFFECTS: Preparation in high and long-term dosage might induce sleepiness.
CONTRA-INDICATIONS: Additional sensitivity toward the component of the preparation.
USING RULE: The preparation is taken perorally. In adults: 1 tablet 3 times a day after meal.
PREGNANCY AND LACTATION: Is not recommended reception in period of pregnancy and lactation, based on the fact that there are no reliable clinical experiments providing the harmlessness of the drug.
INTERACTION WITH OTHER MEDICAL PREPARATIONS AND OTHER TYPE’S INTERACTION: Interoperability of a preparation with other medical products is not described.
OVER DOSAGE: It’s not described.
INFLUENCE ON ABILITY OF DRIVING CARS AND OTHER MECHANISMS: Does not influence on driving cars and other mechanisms.
RELEASE FORM: 20 tablets on a blisters, 2 blisters in the carton box.
In case of visual defects or expiry of validity date, the preparation can not be used.
SHELF LIFE: 4 years.
STORAGE CONDITIONS: Store in a dry, protected from light place, not more than 25ºC temperature.
ORDER OF ISSUE: Pharmaceutical product group III – issued without prescription.
MANUFACTURER: “Neopharmi” Ltd

12th km. D. Agmashenebeli alley. Tbilisi. Georgia.
Tel/Fax: +995 (032) 259-64-46; 259-57-90.